KEITH MAHER, MD

Corporate Board Profile

Tech Score: 0/100

TENAX THERAPEUTICS, INC.

Filing Date	Source Excerpt
2021-04-30	Keith Maher, MD has served as a director since July 2020. Dr. Maher has served as a managing director at Armistice since 2019. From 2007 to 2018, Dr. Maher held senior roles at Schroder Investment Management, Omega Advisors and Gracie Capital.
2022-04-28	Keith Maher, MD, has served as a director since July 2020. Our Board of Directors believes that Dr. Maher’s medical background combined with his experience in investment management qualify him to serve on our Board. Mr. Maher has agreed not to receive compensation for his service as a member of the Board of Directors in light of his position with Armistice Capital, LLC. The Board has determined that Dr. Maher is an independent director.

Filing Date

Source Excerpt

2021-04-30

Keith Maher, MD has served as a director since July 2020. Dr. Maher has served as a managing director at Armistice since 2019. From 2007 to 2018, Dr. Maher held senior roles at Schroder Investment Management, Omega Advisors and Gracie Capital.

2022-04-28

Keith Maher, MD, has served as a director since July 2020. Our Board of Directors believes that Dr. Maher’s medical background combined with his experience in investment management qualify him to serve on our Board. Mr. Maher has agreed not to receive compensation for his service as a member of the Board of Directors in light of his position with Armistice Capital, LLC. The Board has determined that Dr. Maher is an independent director.

Data sourced from SEC filings. Last updated: 2025-07-01